Detalhe da pesquisa
1.
A phase I/randomized phase II study of GM.CD40L vaccine in combination with CCL21 in patients with advanced lung adenocarcinoma.
Cancer Immunol Immunother
; 67(12): 1853-1862, 2018 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-30209589
2.
Phase II evaluation of LY2603618, a first-generation CHK1 inhibitor, in combination with pemetrexed in patients with advanced or metastatic non-small cell lung cancer.
Invest New Drugs
; 34(5): 625-35, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27350064
3.
Systemic and targeted therapies for early-stage lung cancer.
Cancer Control
; 21(1): 21-31, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24357738
4.
Non-small cell lung cancer, version 2.2013.
J Natl Compr Canc Netw
; 11(6): 645-53; quiz 653, 2013 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23744864
5.
Thymomas and thymic carcinomas: Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 11(5): 562-76, 2013 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23667206
6.
The management of patients with stage IIIA non-small cell lung cancer with N2 mediastinal node involvement.
J Natl Compr Canc Netw
; 10(5): 599-613, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22570291
7.
Non-small cell lung cancer.
J Natl Compr Canc Netw
; 10(10): 1236-71, 2012 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23054877
8.
Characteristics and correlates of sleep disturbances in cancer patients.
Support Care Cancer
; 20(2): 357-65, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21311913
9.
Adapting to the brave new world of lung cancer treatment.
Oncology (Williston Park)
; 27(5): 411-2, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25184264
10.
CDK4/6 inhibition stabilizes disease in patients with p16-null non-small cell lung cancer and is synergistic with mTOR inhibition.
Oncotarget
; 9(100): 37352-37366, 2018 Dec 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-30647837
11.
Vorinostat and Concurrent Stereotactic Radiosurgery for Non-Small Cell Lung Cancer Brain Metastases: A Phase 1 Dose Escalation Trial.
Int J Radiat Oncol Biol Phys
; 99(1): 16-21, 2017 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28816142
12.
Overall Survival and Long-Term Safety of Nivolumab (Anti-Programmed Death 1 Antibody, BMS-936558, ONO-4538) in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer.
J Clin Oncol
; 33(18): 2004-12, 2015 Jun 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-25897158
13.
Phase 2 study of concurrent cetuximab plus definitive thoracic radiation therapy followed by consolidation docetaxel plus cetuximab in poor prognosis or elderly patients with locally advanced non-small cell lung cancer.
Int J Radiat Oncol Biol Phys
; 90(4): 828-33, 2014 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25216856
14.
Evaluation of antitumor activity using change in tumor size of the survivin antisense oligonucleotide LY2181308 in combination with docetaxel for second-line treatment of patients with non-small-cell lung cancer: a randomized open-label phase II study.
J Thorac Oncol
; 9(11): 1704-8, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25436803
15.
A phase I, pharmacokinetic, and pharmacodynamic study of panobinostat, an HDAC inhibitor, combined with erlotinib in patients with advanced aerodigestive tract tumors.
Clin Cancer Res
; 20(6): 1644-55, 2014 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24429877
16.
Randomized international phase III trial of ERCC1 and RRM1 expression-based chemotherapy versus gemcitabine/carboplatin in advanced non-small-cell lung cancer.
J Clin Oncol
; 31(19): 2404-12, 2013 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23690416